Pia Roering
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Cells and Metastasis, DNA Repair Mechanisms, Virus-based gene therapy research, PARP inhibition in cancer therapy
Most-Cited Works
- → A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients(2018)112 cited
- → 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer(2015)54 cited
- → ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors(2019)53 cited
- → Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes(2011)20 cited
- → REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker(2016)19 cited
- → Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses(2019)17 cited
- → Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer(2017)16 cited
- → Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status(2022)12 cited
- → Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition(2021)8 cited
- → 1546 Artificial Intelligence-Assisted Digital Analysis Tool for Prognostic Biomarker Discovery in High-Grade Serous Carcinoma(2025)